✦ LIBER ✦

Chemotherapy dose reduction and delay in clinical practice: evaluating the risk to patient outcome in adjuvant chemotherapy for breast cancer

✍ Scribed by J Chang

Book ID: 117666906
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 81 KB
Volume: 36
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(99)00259-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast cancer adjuvant chemotherapy dosi

Breast cancer adjuvant chemotherapy dosing in obese patients : Dissemination of information from clinical trials to clinical practice

✍ Christopher G. Greenman; Christina H. Jagielski; Jennifer J. Griggs 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

## Abstract ## BACKGROUND Substantial variation in adjuvant breast cancer chemotherapy dosing in obese women suggests that there is uncertainty about optimal practices. The purpose of this study was to investigate variations in dose determinations in clinical trial protocols and publications over

Optimising chemotherapy dose density and

Optimising chemotherapy dose density and dose intensity: new strategies to improve outcomes in adjuvant therapy for breast cancer

✍ A.M Gianni; M.J Piccart 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 72 KB

High dose chemotherapy in the adjuvant s

High dose chemotherapy in the adjuvant setting for high risk breast cancer patients — Results from a randomized study

✍ Jonas Bergh 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Lack of correlation betweenc-erbB-2 over

Lack of correlation betweenc-erbB-2 overexpression and the effect of dose-intensification of adjuvant chemotherapy in high-risk breast cancer patients

✍ C. Thomssen; M. Untch; G. Konecny; A. Lebeau; P. Dettmar; D. Sattler; W. Kuhn; S 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Evaluation of the prognostic value of HE

Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose–dense sequential adjuvant chemotherapy

✍ Ioannis Kostopoulos; Petroula Arapantoni-Dadioti; Helen Gogas; Savvas Papadopoul 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 406 KB

Establishing a Platform for Immunotherap

Establishing a Platform for Immunotherapy: Clinical Outcome and Study of Immune Reconstitution after High-Dose Chemotherapy with Progenitor Cell Support in Breast Cancer Patients

✍ Claude Sportès; Nicole J. McCarthy; Frances Hakim; Seth M. Steinberg; David J. L 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 329 KB